Publications & Multimedia

Cochrane reviews

Cochrane Reviews from READ-It Partners in the Cochrane Database of Systematic Reviews.

Supporting materials

Guidelines

Multimedia resources

READ-It annual reports

Other publications and stories

View all resources

1

Latest resources

Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV

The aim of this review was to determine whether the use of LF‐LAM testing had an effect on death and other patient‐important outcomes in people living with HIV.

Cochrane Systematic Review: NEW

Podcast: Ivermectin for preventing and treating COVID-19

Researchers from the COVID-19 Evidence Ecosystem (CEOsys) project collaborated with the LSTM-based Cochrane Infectious Disease Group (CIDG) to carry out a systematic review, to explore the effects of ivermectin in preventing and treating COVID-19 infection.

1

Update: Piperonyl butoxide (PBO) combined with pyrethroids in insecticide‐treated nets to prevent malaria in Africa

Pyrethroid + PBO bed nets reduce malaria infection in areas of high pyrethroid resistance

Cochrane Systematic Review: UPDATE

Enhancing Public Health Systematic Reviews With Diagram Visualization

Using diagrams to help the reader go straight to the essence of a systematic review.

Peer-reviewed article

Paying for performance to improve the delivery of health interventions in low‐ and middle‐income countries

This review update assesses the effects of pay for performance on the delivery of healthcare services in low- and middle-income countries.

Cochrane Systematic Review: UPDATE

Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis

Does using the Xpert MTB/RIF diagnostic test instead of smear microscopy when evaluating people for tuberculosis reduce death and successful treatment completion?

Cochrane Systematic Review: NEW

Rapid versus standard antimicrobial susceptibility testing to guide treatment of bloodstream infection

Tests for identifying the most suitable antibiotics for a bacterial blood infection: are rapid tests better than standard tests?

Cochrane Systematic Review: NEW

Updated Podcast: Xpert Ultra compared to Xpert MTB/RIF for diagnosing pulmonary tuberculosis and rifampicin resistance in adults

Lead author, Jerry Zifodya from Tulane University in New Orleans, USA, talks about the latest finding in this podcast.

Updated Podcast: How accurate is chest imaging for diagnosing COVID-19?

Lead author of the March 2021 update, Nayaar Islam from The Ottawa Hospital Research Institute in Canada, describes the latest findings in this podcast.

Podcast: How accurate are rapid tests for diagnosing COVID-19?

Several COVID-19 reviews relate to diagnosis. One of these, on the use of rapid point-of-care tests was updated in March 2021. Lead author Jacqueline Dinnes from the University of Birmingham in the UK tells us what they found for antigen tests.

Update (24 Mar 2021): Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

This is a review update of the original version (published 26 August 2020). The authors now include 64 study reports in 78 study cohorts, evaluating 16 antigen and 5 molecular assays.

Cochrane Systematic Review: UPDATE

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.

How accurate are sputum Xpert tests for screening for active pulmonary tuberculosis and rifampicin resistance in adults whether or not they have tuberculosis symptoms?

Cochrane Systematic Review: NEW

WHO consolidated guidelines on tuberculosis Module 2: Screening – Systematic screening for tuberculosis disease

A set of 17 new and updated recommendations for the screening of TB disease have been developed

Dissemination products

Update (16 Mar 2021) Thoracic imaging tests for the diagnosis of COVID‐19

Original version published on 30 September 2020. This is the second update of this review. The review authors included studies in people with suspected COVID‐19 only, and excluded studies in people with confirmed COVID‐19. The evidence is up to date to 30 September 2020.

Cochrane Systematic Review: UPDATE

Pages